Amie Goulbourne

Amie Goulbourne is a seasoned professional in the field of pharmacovigilance and drug safety, currently serving as the SERM Sr Scientific Director at GSK since July 2023. Prior to this role, Amie held the position of Executive Director at Sumitomo Dainippon Pharma Oncology from January 2021 to July 2023. Amie's experience includes significant roles such as Sr Director of PV Operations and Compliance at Boston Biomedical and Senior Director of PV at Biogen, where contributions were made from September 2014 to September 2018. Amie began a career in drug safety at Infinity Pharmaceuticals, serving as Sr Director from November 2008 until September 2014. Academic qualifications include a Master of Public Health from Tufts University School of Medicine and a Bachelor of Science in Biochemistry from Hartwick College.